Haemonetics Corp. (HAE)
108.40
-0.40
(-0.37%)
USD |
NYSE |
Aug 24, 16:00
108.39
-0.01
(-0.01%)
After-Hours: 20:00
Haemonetics Price to Book Value : 5.888 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 5.888 |
| August 21, 2026 | 5.91 |
| August 20, 2026 | 5.878 |
| August 19, 2026 | 5.889 |
| August 18, 2026 | 5.685 |
| August 17, 2026 | 4.904 |
| August 14, 2026 | 4.932 |
| August 13, 2026 | 4.909 |
| August 12, 2026 | 4.962 |
| August 11, 2026 | 4.738 |
| August 10, 2026 | 4.705 |
| August 07, 2026 | 4.772 |
| August 06, 2026 | 4.618 |
| August 05, 2026 | 4.541 |
| August 04, 2026 | 4.638 |
| August 03, 2026 | 4.714 |
| July 31, 2026 | 4.646 |
| July 30, 2026 | 4.607 |
| July 29, 2026 | 4.64 |
| July 28, 2026 | 4.484 |
| July 27, 2026 | 4.341 |
| July 24, 2026 | 4.279 |
| July 23, 2026 | 4.204 |
| July 22, 2026 | 4.239 |
| July 21, 2026 | 4.241 |
| Date | Value |
|---|---|
| July 20, 2026 | 4.246 |
| July 17, 2026 | 4.229 |
| July 16, 2026 | 4.264 |
| July 15, 2026 | 4.165 |
| July 14, 2026 | 4.042 |
| July 13, 2026 | 4.177 |
| July 10, 2026 | 4.139 |
| July 09, 2026 | 4.074 |
| July 08, 2026 | 4.010 |
| July 07, 2026 | 4.068 |
| July 06, 2026 | 4.075 |
| July 02, 2026 | 4.078 |
| July 01, 2026 | 4.066 |
| June 30, 2026 | 4.074 |
| June 29, 2026 | 4.269 |
| June 26, 2026 | 4.392 |
| June 25, 2026 | 4.411 |
| June 24, 2026 | 4.141 |
| June 23, 2026 | 4.136 |
| June 22, 2026 | 4.122 |
| June 18, 2026 | 4.215 |
| June 17, 2026 | 4.133 |
| June 16, 2026 | 4.230 |
| June 15, 2026 | 4.371 |
| June 12, 2026 | 4.444 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Boston Scientific Corp. | 2.844 |
| Integra LifeSciences Holdings Corp. | 1.244 |
| Globus Medical, Inc. | 2.367 |
| Abbott Laboratories | 3.95 |
| AngioDynamics, Inc. | 3.850 |
Price to Book Value Related Metrics
| PE Ratio | 52.87 |
| PS Ratio | 3.740 |
| Price to Free Cash Flow | 17.36 |
| Price | 108.40 |
| Earnings Yield | 1.89% |
| Market Cap | 4.929B |
| Operating PE Ratio | 20.36 |
| Normalized PE Ratio | 32.44 |